Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with CCNU/TMZ.
Neuro-oncology
View this publicationNeuro-oncology
View this publicationThe Journal of comparative neurology
View this publicationThe lancet. Healthy longevity
View this publicationThe American journal of tropical medicine and hygiene
View this publicationThe American journal of tropical medicine and hygiene
View this publicationJournal of medicinal chemistry
View this publicationVaccine
View this publicationThe Journal of infection
View this publicationJournal of the American Heart Association
View this publicationProceedings of the National Academy of Sciences of the United States of America
View this publication